One heart into a retail chain pharmaceutical industry leader Chairman is optimistic about the big health

Yunnan listed company Yunnan Hongxiang One Heart Tang Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as: One Heart Hall) recently because of three things in the listed company's pharmaceutical retail industry: First, the 2017 annual turnover of 7.751 billion yuan, net profit of 423 million yuan, strong red performance in the forefront of the industry has been recognized by the industry; Second, was included in MSCI China A-shares onshore index list, by the industry optimistic and respected;to accelerate the process of international capital
MSCI), also known as MSCI, recently announced MSCI China A-shares onshore index parts adjustment list. The adjustment added 23 stocks, excluding 88. Among the new components, one heart, the common people are the representatives of pharmaceutical retail stocks.
msCI index is the most authoritative: international and domestic investors and institutions more agree. It is the world's largest base index for portfolio managers, with about $10 trillion in assets based on the MSCI index, and 97 of the world's top 100 largest asset managers are clients of the MSCI index.
industry analysts believe that this one-hearted and ordinary people into the city, is a milestone in the process of internationalization of the company's capital market, meaning that the company has made a big step towards the international capital market, the company's future development is very powerful, immeasurable. Entering the city is like giving a magic wand, with this magic wand, a heart will be able to do more, can help more people and enterprises.
s work and efforts should be done to meet the needs of consumers as much as possible, " Yu Hongxuan, chairman of The People's Bank of China, told securities daily.
an exclusive interview with Securities Daily, CFO Tian Jun, a secretary of the U.S. Central Committee, said: "I didn't expect the company to enter, the company didn't get the news in advance, we are with you at the same time to learn the good news." As for many institutions and shareholders evaluation is a milestone in pharmaceutical retail stocks, while the market also analyzed a single-hearted will be overseas development, towards the international capital market and other statements, our response is that the company's overseas markets are not yet laid out, we will, as always, live up to everyone's high expectations, towards the established goal of continuing to work hard, wind and rain, always on the road. " Xiongxiong drugstore top 100 list
industry insiders said: "in the domestic chain of drugstore competitiveness ranking, if there is no single-hearted name is not complete." At
the beginning of July, "2018 National Pharmacy Week and the 13th Annual Meeting of China's Pharmaceutical Industry Top 100" was held in Kunming, Yunnan Province, and was selected by the Southern Institute of Pharmaceutical Economics of the State Food and Drug Administration and other units to take the comprehensive strength and direct strength of chain drugstores as the main consideration indicators of the "China's top 100 comprehensive strength of drugstore chains", "China's chain pharmacies directly engaged in the top 100 list" hot.
"Securities Daily" reporter in Kunming witnessed the strength of a heart, won the "China's drugstore chain directly in the top 100 list", "China's chain drugstore comprehensive strength of the top 100 list of the second." And last year, one heart in the "China's drugstore chain directly in the top 100 list" ranked first, in the "China's drugstore chain comprehensive strength of the top 100 list" ranked third.
in the current A-share market, with a similar chain of pharmacies, there are people, Dasin Lin and Yifeng pharmacy 3. In recent years, the scale of revenue of One Heart, People and DasinLin is close, with revenues of more than 7 billion yuan in 2017. In terms of the number of stores in the four listed pharmaceutical companies, by the end of 2017, there were 5,066, 2,733, 3,146 and 2,059 pharmacies in Yitang, People's, Dasinlin and Yifeng, respectively. The largest number of one-hearted stores.
the layout of "multi-regional decentralized outlets" with other enterprises, the strategy of the one-hearted hall is to implement the "low-area high-density" layout. By the end of the first quarter of this year, the company had 5,155 direct chain stores nationwide, the largest number in the country. According to the annual report, revenue in 2017 was RMB7,751 million, up 24.03 percent year-on-year, and net profit attributable to shareholders of listed companies was RMB423 million, up 19.62 percent year-on-year. Among them, southwest China contributed 6.414 billion yuan in 2017, accounting for 82.75 percent of the company's operating income.
the biggest difference between the same retail chain of pharmacies and the common people? Tian Jun said: "One heart to the largest number of stores, the people are the most widely distributed areas, each has an advantage." There are big ginseng forest pharmacy, Yifeng pharmacy have their own strengths, each has its own characteristics, are China's outstanding pharmacy listed companies representatives. "
" into the city and achieved new expansion results, we should make the market through, to the southwest as the core, South China as the strategic depth, North China as the strategic strategy of the goal of the development of the market. Tian Jun said.chairman is optimistic about the big health
a good enterprise must have three magic weapons, keen judgment, good management and rational management of the boss.
a company founded in poor areas of the west, after more than ten years of development, with Yunnan as the starting point, touched the southwest, south China, northwest, north China, east China, central China, to this day has become the leader of retail pharmacy chains. To lead to bigger and stronger pharmaceutical enterprises in economically developed regions, why is the southwest of a heart?
this has to mention the leader of the one-hearted hall- chairman, Yu Hongxuan.
there have been industry people laugh comments: Gong Hongxuan is like Jin Yong's pen's top master - wind clear, martial arts Gesser, swordsmania god. The difference is that the wind is not accustomed to casual, do not want to be bound to do the leadership, and Yan Hongxuan as a deep in the Yunnan mountains of the peasant children, carrying a medicine from nothing to have bigger and stronger, until now become the industry leader, which hardships can be seen. The greater the ability, the greater the responsibility, but The greater the ambition, the greater the pride.
For the future development and the development of the pharmaceutical retail industry, Yan Hongxuan told the Securities Daily reporter: "At present, the pharmaceutical industry is in a period of great reform, great turning point, due to the reconstruction of the industrial chain, the entire pharmaceutical industry is forming a new competitive landscape, in the new environment, the new era to use new thinking, new tools and new business strategies, the company should make full use of the 'Internet plus' resource integration advantages, to create an online and offline integrated service system." All the work and efforts made by the Church should be aimed at meeting the needs of the people as much as possible.
Let Yan Hongxuan proud that the single-hearted hall was only a simple pharmaceutical retail enterprises, after 18 years of development, has now been expanded to provide customers with prevention, health care, rehabilitation, individual care and sub-health state reversal and other aspects of health life solutions-based integrated service-oriented enterprises;
With the "13th Five-Year Plan" landing, "Healthy China" officially upgraded to the national strategy, and now the booming large health industry, not only in the industry issued more and more vitality, but also gradually developed into a new round of consumption upgrade "wind mouth."
" no disease first treatment, no disease prevention, is now the public's new concept of health, so the whole of China, the world are optimistic about the big health industry, for a heart, we ushered in a good era, we are very confident, must take root in the industry, solid foundation, only in this way, the future development of the company will be a real smooth sailing. He said. (Securities Daily)